479 related articles for article (PubMed ID: 22274571)
1. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.
Tsukamoto K; Matsusue E; Kanasaki Y; Kakite S; Fujii S; Kaminou T; Ogawa T
Neuroradiology; 2012 Sep; 54(9):947-55. PubMed ID: 22274571
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
Paviour DC; Thornton JS; Lees AJ; Jäger HR
Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
[TBL] [Abstract][Full Text] [Related]
3. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
[TBL] [Abstract][Full Text] [Related]
4. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
Seppi K; Schocke MF; Esterhammer R; Kremser C; Brenneis C; Mueller J; Boesch S; Jaschke W; Poewe W; Wenning GK
Neurology; 2003 Mar; 60(6):922-7. PubMed ID: 12654954
[TBL] [Abstract][Full Text] [Related]
6. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
[TBL] [Abstract][Full Text] [Related]
7. Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.
Sjöström H; Surova Y; Nilsson M; Granberg T; Westman E; van Westen D; Svenningsson P; Hansson O
Sci Rep; 2019 Apr; 9(1):6079. PubMed ID: 30988382
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD.
Schocke MF; Seppi K; Esterhammer R; Kremser C; Jaschke W; Poewe W; Wenning GK
Neurology; 2002 Feb; 58(4):575-80. PubMed ID: 11865135
[TBL] [Abstract][Full Text] [Related]
10. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
[TBL] [Abstract][Full Text] [Related]
11. The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders.
Wadia PM; Howard P; Ribeirro MQ; Robblee J; Asante A; Mikulis DJ; Lang AE
Can J Neurol Sci; 2013 May; 40(3):389-402. PubMed ID: 23603177
[TBL] [Abstract][Full Text] [Related]
12. Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.
Surova Y; Nilsson M; Lätt J; Lampinen B; Lindberg O; Hall S; Widner H; Nilsson C; van Westen D; Hansson O
Neuroradiology; 2015 Nov; 57(11):1079-91. PubMed ID: 26253801
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.
Eckert T; Sailer M; Kaufmann J; Schrader C; Peschel T; Bodammer N; Heinze HJ; Schoenfeld MA
Neuroimage; 2004 Jan; 21(1):229-35. PubMed ID: 14741660
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792
[TBL] [Abstract][Full Text] [Related]
15. Morphometry MRI in the differential diagnosis of parkinsonian syndromes.
Gama RL; Távora DF; Bomfim RC; Silva CE; Bruin VM; Bruin PF
Arq Neuropsiquiatr; 2010 Jun; 68(3):333-8. PubMed ID: 20602031
[TBL] [Abstract][Full Text] [Related]
16. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy.
Reginold W; Lang AE; Marras C; Heyn C; Alharbi M; Mikulis DJ
Parkinsonism Relat Disord; 2014 Feb; 20(2):222-5. PubMed ID: 24239142
[TBL] [Abstract][Full Text] [Related]
18. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
[TBL] [Abstract][Full Text] [Related]
19. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
Paviour DC; Price SL; Stevens JM; Lees AJ; Fox NC
Neurology; 2005 Feb; 64(4):675-9. PubMed ID: 15728291
[TBL] [Abstract][Full Text] [Related]
20. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
Sjöström H; Granberg T; Westman E; Svenningsson P
Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
